Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$19.74−0.06 (-0.30%)
Close on Nov 17, 2026Market cap $999.81MP/E –Yield –
Cryoport EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Cryoport's EV/EBITDA was 203.3× on Apr 29, 2022.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 203.3× | −592.8 |
| 2021 | Dec 31, 2021 | 796.1× | – |
See a number that looks wrong?